Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.1 USD | +6.25% | +6.00% | -21.21% |
09/05 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
08/05 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.21% | 1.12B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Transcript : Pharvaris N.V. Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 04